Key result
The hemostatic system accelerates plaque vulnerability to thrombosis in experimental models, although clinical evidence supporting this effect remains weak.
Design
Review
This review highlights the discrepancy between experimental data and clinical evidence regarding the hemostatic system's role in accelerating plaque vulnerability to thrombosis.
Experimental data suggest that the hemostatic system can accelerate plaque vulnerability to thrombosis in vivo. However, clinical support for these findings remains weak. This comprehensive summary reviews the evidence.
No takes yet. Share an insight, caveat, or question.
Borissoff et al. (2011) studied this question. The hemostatic system accelerates plaque vulnerability to thrombosis in experimental models, although clinical evidence supporting this effect remains weak.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: